MicroRNA-339-5p inhibits lipopolysaccharide-induced rat mesangial cells by regulating the Syk/Ras/c-Fos pathway

Jia Rong Gao1,2, Miao Miao Shi3, Hui Jiang4

  • 1Department of Pharmacy, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, 230031, Anhui, China. 2020205219007@stu.ahtcm.edu.cn.

Insights

MicroRNA-339-5p (miR-339-5p) inhibits inflammation and proliferation in rat mesangial cells during nephritis. Overexpression of miR-339-5p suppresses the Syk/Ras/c-Fos pathway, reducing inflammatory cytokine release.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Immunology

Background:

  • Chronic glomerulonephritis (CGN) involves complex inflammatory responses.
  • MicroRNA-339-5p (miR-339-5p) is implicated in various inflammatory conditions.
  • The specific role of miR-339-5p in CGN pathogenesis is not well understood.

Purpose of the Study:

  • To investigate the function of miR-339-5p in lipopolysaccharide (LPS)-induced nephritis in rat mesangial cells (HBZY-1).
  • To elucidate the molecular mechanisms underlying miR-339-5p's effects on inflammation and cell proliferation.

Main Methods:

  • Real-time RT-qPCR and Western blot to assess miR-339-5p and Syk/Ras/c-Fos pathway expression.
  • Double luciferase assay to confirm direct targeting of Syk by miR-339-5p.
  • Cell Counting Kit-8, flow cytometry, and ELISA to evaluate cell viability, cell cycle, and inflammatory cytokine levels (IL-1β, IL-10, IL-6, TNF-α).

Main Results:

  • LPS treatment increased HBZY-1 cell viability, proliferation, and inflammatory cytokine production while altering cell cycle progression.
  • Overexpression of miR-339-5p counteracted LPS effects, inhibiting cell viability and proliferation.
  • miR-339-5p significantly downregulated the Syk/Ras/c-Fos signaling pathway and reduced inflammatory cytokine levels.

Conclusions:

  • miR-339-5p plays a protective role in LPS-induced nephritis.
  • The inhibitory effects of miR-339-5p on cell proliferation and inflammation are mediated through the regulation of the Syk/Ras/c-Fos signaling pathway.